Health ❯Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs

Tirzepatide

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

The decision impacts access to affordable alternatives and raises concerns about the future of weight-loss treatments for uninsured patients.

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Eli Lilly Introduces Affordable Zepbound Vials to Address Obesity Drug Shortage

Markets Anticipate Fed Rate Cut as Dollar Weakens

Eli Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks